The changing landscape of anti-lymphoma drug clinical trials in mainland China in the past 15 years (2005–2020): A systematic review

BACKGROUND: To depict a comprehensive changing landscape of anti-lymphoma drug clinical trials in mainland China from 2005 to 2020. METHODS: A systematic review was conducted on the China National Medical Products Administration Center for Drug Evaluation platform, the Chinese Clinical Trial Registr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Haizhu, Zhou, Yu, Han, Xiaohong, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315394/
https://www.ncbi.nlm.nih.gov/pubmed/34327425
http://dx.doi.org/10.1016/j.lanwpc.2021.100097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315394/
https://www.ncbi.nlm.nih.gov/pubmed/34327425
http://dx.doi.org/10.1016/j.lanwpc.2021.100097

Ejemplares similares